- This event has passed.
POSTPONED – 2014 CBD S&T Conference
November 17, 2014 - November 21, 2014
Editor’s Note: The DTRA Chem-Bio Defense team announced on October 1, 2014 that this meeting is postponed, with a new projected time-frame of May 2015.
The 2014 CBD S&T Conference for Chemical and Biological Defense Science and Technology will take place November 17-21, 2014 in St. Louis, Missouri.
Hosted by the Defense Threat Reduction Agency (DTRA), the event offers a unique opportunity to exchange ideas, interact with elite researchers, and engage with federal agencies involved in Chemical and Biological Defense. The theme of this year’s conference is “Finding Tomorrow’s Solutions in Today’s Environment”.
Through keynote, oral, and poster presentations, the conference will address key areas including:
- Novel Threat and Disruptive Chemical and Biological Discovery
- Dynamic Functional Materials
- Applied Mathematics and Innovative Computational Tools
- Flexible Design, Synthesis and Manufacturing; and
- Systems Biology and Engineering
- Disease Surveillance, Characterization and Point of Need Diagnostics
- Adaptive Medical Therapeutics and Technologies
- Rapid Response and Recovery Science and Technology
- Threat Activity Sensing and Reporting
- Advances in Chem Bio Defense Technologies
- Industry Views on Technology Challenges and Needs
Attendees will have the opportunity to interact and collaborate with other researchers concerning the medical and physical sciences related to chemical and biological defense. Attendees will also be able to network with DTRA science and technology managers and other members of the Chem-Bio Technologies team.
The last iteration of the Chemical and Biological Defense Science and Technology (CBD S&T) Conference brought together more than 1,700 attendees, with nearly 200 oral presentations and 700+ posters.
Learn about key issues in the Chem-Bio Defense industry as seen by leading researchers. Want to participate? Submit an abstract by for any of the following areas:
- Enhancing Advanced Technology Transition for Mission Applications
- Advances in Protection and Hazard Mitigation Technologies
- Operational Effects and Risk Analysis
- In vitro/Ex vivo Human Organ-Specific Models
- Human Efficacious Dose Projections and the Animal Rule
- Fate of CB Particulates in the Environment
- Catalytic Medical Countermeasures for Chemical Defense
- Optimizing Recombinant Butyrylcholinesterase as a Medical Countermeasure for Nerve Agents
- Understanding and Enhancing Innate Protective Responses to Chemical/Molecular Toxicants
- Understanding of Human Biological Barriers in Threat Environments
- In-vivo Micro/Nanoscale Motors, Machines and Needles for Future Medical Countermeasures and Theranostics
- Predictive Molecular Partitioning and Low-power Separation/Concentration
- Emerging Nanotechnology Advancements with Potential Counter-WMD Applications
- Tularemia Vaccine Target Discovery
- Q Fever Vaccine Development
- Considerations in Accelerating MCM Development against Infectious Pathogens: Sciences, Technology, and Regulatory Perspectives
- Host-directed Biological Therapeutics
- Pathogen-directed Biological Therapeutics
- Countermeasure Technology Integration and Transformation for Biodefense
- Avoiding and Overcoming Antimicrobial Resistance of Bioagents
- Biosurveillance Ecosystem (BSVE) – the Analyst Workbench, the App Store, and Program Interactions
- Cheap, Remote Chemical Detection
- Developing Host Biomarkers into an Early Warning System for Infection
Please visit DTRA’s CBD S&T Conference website for more information.